| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.008 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.01 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.13 | 0.01 |